Elevated dopamine receptor-coupled Gs protein measures in mononuclear leukocytes of patients with schizophrenia

被引:20
作者
Avissar, S [1 ]
Barki-Harrington, L
Nechamkin, Y
Roitman, G
Schreiber, G
机构
[1] Ben Gurion Univ Negev, Dept Clin Pharmacol, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Dept Psychiat, IL-84105 Beer Sheva, Israel
关键词
beta-adrenergic; dopamine; G protein; muscarinic; schizophrenia;
D O I
10.1016/S0920-9964(00)00038-4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Heterotrimeric G proteins play a pivotal role in post-receptor information transduction and were previously implicated in the pathophysiology and treatment of mood disorders. Changes previously detected in G protein levels in post-mortem brain of patients with schizophrenia could reflect effects of antipsychotic medication. The present study aims at quantitatively and functionally evaluating receptor-coupled G proteins in mononuclear leukocytes obtained from 23 untreated patients with schizophrenia and 30 healthy subjects in an attempt to unravel a pattern of G protein measures in schizophrenia distinctive from patterns previously obtained in mood disorders. Dopamine-enhanced guanine nucleotide binding capacity to G(s) protein through D-1/D-5 receptor in mononuclear leukocytes of untreated patients with schizophrenia was significantly increased in comparison with healthy subjects, and positively correlated with both the total PANSS score and the positive subscale. beta -Adrenergic and muscarinic receptor-coupled G protein functions. as well as G(s)alpha, G(i)alpha and G beta immunoreactivities, were similar to healthy subjects. These findings, distinctive for schizophrenia, unrelated to drug treatment, and differential from previous findings in mania and depression, may potentially help to differentially diagnose, after the first psychotic episode. between the major psychoses: schizophrenia and manic-depressive illness. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 47
页数:11
相关论文
共 60 条
[31]  
2-B
[32]   PARKINSONS-DISEASE - PAST, PRESENT, AND FUTURE [J].
KOPIN, IJ .
NEUROPSYCHOPHARMACOLOGY, 1993, 9 (01) :1-12
[33]  
KUROSE H, 1986, J BIOL CHEM, V261, P6423
[34]  
LAPPIN D, 1982, CLIN EXP IMMUNOL, V47, P606
[35]   INVOLVEMENT OF PERIPHERAL AND CENTRAL CATECHOLAMINE SYSTEMS IN NEURAL IMMUNE INTERACTIONS [J].
LIVNAT, S ;
FELTEN, SY ;
CARLSON, SL ;
BELLINGER, DL ;
FELTEN, DL .
JOURNAL OF NEUROIMMUNOLOGY, 1985, 10 (01) :5-30
[36]  
MCCOLL SR, 1993, J IMMUNOL, V150, P4550
[37]   COUPLING OF DOPAMINE-D1 RECOGNITION SITES WITH ADENYLATE-CYCLASE IN NUCLEI ACCUMBENS AND CAUDATUS OF SCHIZOPHRENICS [J].
MEMO, M ;
KLEINMAN, JE ;
HANBAUER, I .
SCIENCE, 1983, 221 (4617) :1304-1307
[38]  
MURAYAMA T, 1984, J BIOL CHEM, V259, P761
[39]   EXPRESSION OF THE D3 DOPAMINE-RECEPTOR GENE AND A NOVEL VARIANT TRANSCRIPT GENERATED BY ALTERNATIVE SPLICING IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
NAGAI, Y ;
UENO, S ;
SAEKI, Y ;
SOGA, F ;
YANAGIHARA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) :368-374
[40]   INCREASE IN [H-3] CAMP BINDING-SITES AND DECREASE IN G(I-ALPHA) AND G(O-ALPHA) IMMUNOREACTIVITIES IN LEFT TEMPORAL CORTICES FROM PATIENTS WITH SCHIZOPHRENIA [J].
NISHINO, N ;
KITAMURA, N ;
HASHIMOTO, T ;
KAJIMOTO, Y ;
SHIRAI, Y ;
MURAKAMI, N ;
NAKAI, T ;
KOMURE, O ;
SHIRAKAWA, O ;
MITA, T ;
NAKAI, H .
BRAIN RESEARCH, 1993, 615 (01) :41-49